<?xml version='1.0' encoding='utf-8'?>
<document id="20219852"><sentence text="Pharmacokinetic interaction between JBP485 and cephalexin in rats."><entity charOffset="47-57" id="DDI-PubMed.20219852.s1.e0" text="cephalexin" /></sentence><sentence text="The purpose of this study was to investigate the pharmacokinetic mechanism of interaction between JBP485 (cyclo-trans-4-L-hydroxyprolyl-L-serine, a dipeptide) and cephalexin when they were coadministered in rats"><entity charOffset="106-144" id="DDI-PubMed.20219852.s2.e0" text="cyclo-trans-4-L-hydroxyprolyl-L-serine" /><entity charOffset="163-173" id="DDI-PubMed.20219852.s2.e1" text="cephalexin" /><pair ddi="false" e1="DDI-PubMed.20219852.s2.e0" e2="DDI-PubMed.20219852.s2.e0" /><pair ddi="false" e1="DDI-PubMed.20219852.s2.e0" e2="DDI-PubMed.20219852.s2.e1" /></sentence><sentence text=" The plasma concentrations of JBP485 and cephalexin were both decreased significantly after oral combination, but little difference was observed after simultaneous intravenous administration of the two agents, suggesting that the interaction target localized in the intestine during the absorption process"><entity charOffset="41-51" id="DDI-PubMed.20219852.s3.e0" text="cephalexin" /></sentence><sentence text=" The uptake in everted intestinal sacs and absorption in jejunal perfusions of JBP485 and cephalexin were dramatically reduced after drug combination"><entity charOffset="90-100" id="DDI-PubMed.20219852.s4.e0" text="cephalexin" /></sentence><sentence text=" When JBP485 and cephalexin were coadministered, both the decrease in accumulative renal excretion (81"><entity charOffset="17-27" id="DDI-PubMed.20219852.s5.e0" text="cephalexin" /></sentence><sentence text="9-68" /><sentence text="1% of JBP485 and 91" /><sentence text="8-74" /><sentence text="5% of cephalexin) and in renal clearance (2"><entity charOffset="6-16" id="DDI-PubMed.20219852.s9.e0" text="cephalexin" /></sentence><sentence text="89-1" /><sentence text="87 ml/min/kg JBP485 and 2" /><sentence text="23-1" /><sentence text="58 ml/min/kg cephalexin) indicated that transporter(s) other than H(+)/peptide transporter (PEPT) 2 are involved in the process of excretion"><entity charOffset="13-23" id="DDI-PubMed.20219852.s13.e0" text="cephalexin" /></sentence><sentence text=" Probenecid could reduce renal excretion of JBP485 and cephalexin"><entity charOffset="1-11" id="DDI-PubMed.20219852.s14.e0" text="Probenecid" /><entity charOffset="55-65" id="DDI-PubMed.20219852.s14.e1" text="cephalexin" /><pair ddi="false" e1="DDI-PubMed.20219852.s14.e0" e2="DDI-PubMed.20219852.s14.e0" /><pair ddi="false" e1="DDI-PubMed.20219852.s14.e0" e2="DDI-PubMed.20219852.s14.e1" /></sentence><sentence text=" Moreover, the decreased uptake of JBP485 with probenecid, p-aminohippuate, or benzylpenicillin in kidney slices could be explained by an inhibition in the kidney via organic anion transporters (OATs), at least in part"><entity charOffset="47-57" id="DDI-PubMed.20219852.s15.e0" text="probenecid" /><entity charOffset="59-74" id="DDI-PubMed.20219852.s15.e1" text="p-aminohippuate" /><entity charOffset="79-95" id="DDI-PubMed.20219852.s15.e2" text="benzylpenicillin" /><pair ddi="false" e1="DDI-PubMed.20219852.s15.e0" e2="DDI-PubMed.20219852.s15.e0" /><pair ddi="false" e1="DDI-PubMed.20219852.s15.e0" e2="DDI-PubMed.20219852.s15.e1" /><pair ddi="false" e1="DDI-PubMed.20219852.s15.e0" e2="DDI-PubMed.20219852.s15.e2" /><pair ddi="false" e1="DDI-PubMed.20219852.s15.e1" e2="DDI-PubMed.20219852.s15.e1" /><pair ddi="false" e1="DDI-PubMed.20219852.s15.e1" e2="DDI-PubMed.20219852.s15.e2" /></sentence><sentence text=" The accumulation of JBP485 in human (h) OAT1- or hOAT3-human embryonic kidney (HEK) 293 cells was greater than that in vector-HEK293 cells, and the uptake could be inhibited by probenecid" /><sentence text=" These findings further confirmed that the pharmacokinetic mechanism of the drug-drug interaction between JBP485 and cephalexin could be explained by their inhibition of the same transporters in the intestinal mucosa (PEPT1) and kidneys (PEPT2 and OATs)"><entity charOffset="117-127" id="DDI-PubMed.20219852.s17.e0" text="cephalexin" /></sentence><sentence text=" We provide the first evidence that JBP485 is not only a substrate of PEPTs but also is excreted through OATs" /><sentence text="" /></document>